Emily Meyering is a medical device and pharmaceutical chemist with over 10 years of experience designing products. Emily is very passionate about innovation and has 8 issued patents with over 15 applications pending both in the U.S. and internationally.
Emily obtained her B.S. in Biochemistry from the University of St. Thomas and a M.S. in Organic Chemistry from the University of California - San Diego. She worked for Medtronic during and after college developing novel biodegradable polymers and drug-eluting stents. After graduate school, Emily worked as a formulation chemist developing natural, biodegradable polymers for medical implants at SurModics.
In 2011, Emily joined American Medical Systems, where she met Ben and Greg. She created a drug-eluting pelvic floor mesh and a novel pre-clinical testing model with Colorado State University. Ms. Meyering co-led several company-wide innovation summits where she fostered collaboration and problem-solving for cross-functional teams. Emily and Ben Arcand were awarded the AMS Innovation Award for the development of a new platform technology in soft tissue repair.
Emily joined Minnetronix in 2013 where she led a technical team from bench prototypes to FDA submission in 17 months. Currently, she is the Director of Research and Development at SpineThera, a startup pharmaceutical company developing a drug product to treat back pain.
Ms. Meyering has always been passionate in her love of animals, especially her pet tree frogs and 5 year old Rhodesian Ridgeback, Thor. In her extensive preclinical activites working with veterinarians across the country, she has come to deeply appreciate the work they do and the needs they have in treating their patients.